Exscientia plc
NASDAQ:EXAI
Overview | Financials
Company Name | Exscientia plc |
Symbol | EXAI |
Currency | USD |
Price | 4.84 |
Market Cap | 633,178,480 |
Dividend Yield | 0% |
52-week-range | 4.84 - 4.84 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Prof. Andrew L. Hopkins DPHIL, FMEDSCI, FRSE FRSC |
Website | https://www.exscientia.ai |
An error occurred while fetching data.
About Exscientia plc
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD